EAM Global Investors’s Cardlytics CDLX Stock Holding History

EAM Global Investors’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,091	Closed	-$2.57M	–	113
2019 Q4	$2.57M	Sell	4,091 -2,048	-33%	-$1M	1.03%	23
2019 Q3	$2.06M	Buy	6,139 +452	+8%	+$145K	1%	31
2019 Q2	$1.48M	Buy	+5,687	New	+$1.14M	0.63%	81
2018 Q3	–	Sell	-5,220	Closed	-$1.14M	–	156
2018 Q2	$1.14M	Buy	+5,220	New	+$966K	0.56%	108

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

EAM Global Investors's CDLX Position: Q1 2020 in Review

EAM Global Investors sold out of Cardlytics (CDLX) in Q1 2020, closing a stake of 4,091 shares — an estimated $2.57M sold.

EAM Global Investors first reported a position in CDLX in Q2 2018 and held it in 4 quarters. The position peaked at $2.57M in Q4 2019. 142 funds tracked by Wall St. Rank hold CDLX as of Q1 2020.

EAM Global Investors reported no remaining Cardlytics position as of Q1 2020 after selling out during the quarter.
EAM Global Investors sold 4,091 Cardlytics shares in Q1 2020, an estimated $2.57M.
EAM Global Investors first reported a position in Cardlytics in Q2 2018 and held it in 4 quarters.
EAM Global Investors's Cardlytics position peaked at $2.57M in Q4 2019.
142 funds tracked by Wall St. Rank held Cardlytics as of Q1 2020.

Based on EAM Global Investors's 13F filing for Q1 2020, filed 13 May 2020.